000 01702 a2200517 4500
005 20250516134748.0
264 0 _c20131021
008 201310s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2013.52
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLogan, A C
245 0 0 _aMinimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.
_h[electronic resource]
260 _bLeukemia
_cAug 2013
300 _a1659-65 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Heavy Chains
_xgenetics
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm, Residual
_xdiagnosis
650 0 4 _aPrognosis
650 0 4 _aRecurrence
650 0 4 _aReproducibility of Results
650 0 4 _aTime Factors
700 1 _aZhang, B
700 1 _aNarasimhan, B
700 1 _aCarlton, V
700 1 _aZheng, J
700 1 _aMoorhead, M
700 1 _aKrampf, M R
700 1 _aJones, C D
700 1 _aWaqar, A N
700 1 _aFaham, M
700 1 _aZehnder, J L
700 1 _aMiklos, D B
773 0 _tLeukemia
_gvol. 27
_gno. 8
_gp. 1659-65
856 4 0 _uhttps://doi.org/10.1038/leu.2013.52
_zAvailable from publisher's website
999 _c22514298
_d22514298